REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Glenmark Pharmaceuticals Sk, S. R. O. (Slovakia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Other Miscellaneous Nondurable Goods Merchant Wholesalers
Secondary Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers | Research and Development in the Social Sciences and Humanities | Advertising Agencies | Marketing Research and Public Opinion Polling
Full name: Glenmark Pharmaceuticals Sk, S. R. O. Profile Updated: July 11, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Glenmark Pharmaceuticals Sk, S. R. O. is an enterprise based in Slovakia. Its main office is in Bratislava. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was first established on May 04, 2005. 25 - 49 (2025) employees currently work for Glenmark Pharmaceuticals Sk, S. R. O.. There was a net sales revenue increase of 13.31% reported in Glenmark Pharmaceuticals Sk, S. R. O.’s latest financial highlights for 2025. Its’ total assets recorded a negative growth of 5.31%. In 2025, Glenmark Pharmaceuticals Sk, S. R. O.’s net profit margin increased by 4.2%.

Headquarters
Tomasikova, 64
Bratislava; Bratislavsky; Postal Code: 83104

Contact Details: Purchase the Glenmark Pharmaceuticals Sk, S. R. O. report to view the information.

Website: https://www.glenmarkpharma.com

Basic Information
Total Employees:
Purchase the Glenmark Pharmaceuticals Sk, S. R. O. report to view the information.
Registered Capital:
Purchase the Glenmark Pharmaceuticals Sk, S. R. O. report to view the information.
Financial Auditors:
Purchase the Glenmark Pharmaceuticals Sk, S. R. O. report to view the information.
Incorporation Date:
May 04, 2005
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Glenmark Pharmaceuticals Sk, S. R. O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
13.31%▲
Total Operating Revenue
8.48%▲
Operating Profit
275.26%▲
EBITDA
257.33%▲
Net Profit/Loss for the Period
440.86%▲
Total Assets
-5.31%▼
Total Equity
51.13%▲
Operating Profit Margin
5%▲
Net Profit Margin
4.2%▲
Return on Equity (ROE)
24.38%▲
Debt / Equity
-0.11%▼
Quick Ratio
0.19%▲
Cash Ratio
-0.09%▼

Similar companies

Doropharm Health S.R.O.
 
Teva Pharmaceuticals Slovakia S.R.O.
Medtronic Slovakia S. R. O.
 
Merck Sharp & Dohme, S.R.O.
Amgen Slovakia S.R.O.
 
Jntl Consumer Health (Slovakia), S.R.O.
Meditrade Spol. S R. O.
 
Worwag Pharma Slovensko S. R. O.
Intravena S.R.O.
 
Intermedical Plus, S.R.O.
Zentiva, a.s.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo